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Abstract 
Background 
Malaria and anaemia (Haemoglobin<11 g/dl) remain frequent in tropical regions and are 
closely associated. Although anaemia aetiologies are known to be multi-factorial, most 
studies in malaria endemic areas have been confined to analysis of possible associations 
between anaemia and individual factors such as malaria. A case control study involving 
children aged from 1 to 10 years was conducted to assess some assumed contributors to 
anaemia in the area of Bonconto Health post in Senegal. 
Methods 
Study participants were randomly selected from a list of children who participated in a survey 
in December 2010. Children aged from 1 to 10 years with haemoglobin level below 11 g/dl 
represented cases (anaemic children). Control participants were eligible if of same age group 
and their haemoglobin level was >= 11 g/dl. For each participant, a physical examination was 
done and anthropometric data collected prior to a biological assessment which included: 
malaria parasitaemia infection, intestinal worm carriage, G6PD deficiency, sickle cell 
disorders, and alpha-talassaemia. 
Results 
Three hundred and fifty two children < 10 years of age were enrolled (176 case and 176 
controls). In a logistic regression analysis, anaemia was significantly associated with malaria 
parasitaemia (aOR=5.23, 95%CI[1.1-28.48]), sickle cell disorders (aOR=2.89, 95%CI[1,32-
6.34]), alpha-thalassemia (aOR=1.82, 95%CI[1.2-3.35]), stunting (aOR=3.37, 95%CI[1.93-
5.88], age ranged from 2 to 4 years (aOR=0.13, 95%CI[0.05-0.31]) and age > 5 years 
(aOR=0.03, 95%CI[0.01-0.08]). Stratified by age group, anaemia was significantly associated 
with stunting in children less than 5 years (aOR=3.1 95%CI[1.4 – 6.8]), with, sickle cell 
disorders (aOR=3.5 95%CI [1.4 – 9.0]), alpha-thalassemia (or=2.4 95%CI[1.1–5.3]) and 
stunting (aOR=3.6 95%CI [1.6–8.2]) for children above 5 years. No association was found 
between G6PD deficiency, intestinal worm carriage and children’s gender. 
Conclusion 
Malaria parasitaemia, stunting and haemoglobin genetic disorders represented the major 
causes of anaemia among study participants. Anaemia control in this area could be achieved 
by developing integrated interventions targeting both malaria and malnutrition. 
Keywords 
Anaemia, Malaria, Haemoglobin disorders, Malnutrition, Children 
Background 
Anaemia (haemoglobin < 11 g/dl) is a major public health problem affecting 1.62 billion 
people globally [1]. Africa and Asia are the most affected regions with more than 85% of the 
absolute anaemia burden [1]. Children and women of reproductive age are most at risk, with 
global anaemia prevalence estimates of 47% in children younger than 5 years, 42% in 
pregnant woman and 30% in non-pregnant woman aged 15 – 49 years. [1,2] Causes of 
anaemia can be broadly classified into decreased erythrocyte production or increased loss of 
erythrocytes through increased destruction (haemolysis) or blood loss or both [2]. In 
developing countries, anaemia aetiologies are multi-factorial, and infectious diseases, genetic 
haemoglobin disorders, as well as malnutrition, can play a major role in anaemia occurrence 
[3]. 
Infectious diseases such as intestinal parasite infections contribute to anaemia through 
impaired absorption and metabolism of iron and other micronutrients or increased nutrient 
losses. For instance, soil-transmitted helminth infections commonly found in tropical regions 
are a major cause of anaemia [4,5]. Other parasitic infections such as schistosomiasis are 
frequent in sub-Saharan countries [6] and can lead to anaemia due to iron deficiency from 
blood lost from haematuria caused by Schistosoma haematobium, or diarrhoea due to 
Schistosoma mansoni. Malaria remains an important cause of morbidity in tropical regions 
with an estimated 149 to 274 million cases and 539 000 to 906 000 deaths worldwide [7]. 
Plasmodium falciparum is the most pathogenic species and can lead to increased erythrocyte 
destruction and thus to anaemia [8]. 
Genetic haemoglobin disorders, which are the consequence from irregular structural or 
reduced production of the globin chains of haemoglobin, can result in anaemia [2]. Several 
studies have investigated the distribution and functional consequences of these genetic 
disorders; while it is clear that heterozygotes (carriers) of the mutations are partially protected 
against malaria, [9,10] their contribution to the global anaemia burden remains less clear [11] 
and studies are becoming even more relevant [12] when malaria is declining, as in Senegal, 
and several other previous high-endemic areas on anaemia [13,14]. Sickle-cell disorders are 
associated with haemolytic anaemia and an estimated 2.28 individuals per 1000 births 
worldwide are affected by sickle-cell disorders [15]. Sickle cell disease is the homozygous 
state for haemoglobin S (HbSS), caused by a mutation in the β-haemoglobin. Sickle cell trait 
is the heterozygous state of this haemoglobinopathy (mainly HbAS) [12]. Alpha thalassemia 
is also a genetic haemoglobinopathy highly prevalent in Sub-Saharan Africa, Asia and 
Melanesia [10]. Normal individuals have duplicate α-genes on each chromosome 16. By 
contrast, those with heterozygous α+− thalassemia have loss of 1 α-gene, resulting in 3 
functional α-genes (−α/αα), whereas homozygotes have only 2 functional α-genes (−α/-α). 
Heterozygote individuals are characterized by slight haematological changes, whereas 
homozygote individuals generally have mild microcytic anaemia [16]. 
Another prevalent genetic disorder in previous and present malarious areas is glucose-6-
phosphate-dehydrogenase (G6PD) deficiency. G6PD deficiency is a common chromosome x-
linked red blood cell enzymopathy with several polymorphisms arisen from mutations in the 
G6PD gene [17]. In sub-Saharan Africa, G6PD is essentially a tri-allelic polymorphism. 
G6PD (B) is the most common allele with normal enzymatic activity; G6PD (A) is associated 
with a single amino acid substitution at codon (c) 126 where Asn is changed to Asp (N126D), 
causing around 85% of the normal enzymatic activity. The G6PD (A-) deficiency allele has a 
single amino acid substitution at c68 from Val to Met (V68M), always in conjunction with 
the N126D mutation [18]. The G6PD (A-) variant has only around 12% of normal enzymatic 
activity with frequencies of 5– 25% of the affected population in sub-Saharan Africa [19,20]. 
Although most individuals with the G6PD (A-) polymorphic variant are asymptomatic, acute 
haemolytic anaemia can manifest in hetero and homozygote females as well as hemizygote 
males under oxidative stress of the red blood cells [19]. This condition can be induced by 
infections, anti-inflammatory agents and chemotherapeutics, including anti-malarials such as 
primaquine and dapsone [17]. 
Malnutrition is also known to be a factor associated with anaemia [21]. Restricted access to 
diverse micronutrients particularly in vulnerable groups living in low-income countries can 
contribute to malnutrition as well as to anaemia [2]. 
Overall, in tropical regions anaemia causes present a great diversity. Although anaemia 
aetiologies are multi-factorial, most studies in malaria endemic areas have been confined to 
the anaemia associated with malaria or with other single factors [22-25]. In recent years, 
significant reductions in the incidence of malaria have been reported in several African 
countries where malaria was previously highly to moderately endemic [13]. A study 
conducted in Senegal (2010), showed a significant reduction of malaria cases in children who 
had access to several antimalarial interventions. However, despite the significant reduction of 
malaria, anaemia prevalence remained high in these communities [14]. It remains thus, 
unclear why anaemia is still high in communities who had access to high coverage of 
antimalarial interventions. Therefore, this study was undertaken, to document malaria risks 
for anaemia as well as other possible risks factors and determinants in an area with declining 
of malaria pattern. 
Methods 
Study area 
The study was conducted in the 8 villages covered by the Bonconto health post, which is 
located in the Velingara health district in the South-eastern part of Senegal, 500 km from the 
capital city of Dakar. Mass deworming administration (MDA) program using Mebendazole is 
being promoted in the area of Bonconto health post with two yearly administrations in 
children under 5 years. Reports from the health post records showed coverage of 
mebendazole administration at 95% in December 2010. 
Study design and population 
A cross sectional survey was carried out in December 2010 at the end of the malaria 
transmission season, and 3 weeks after the MDA campaign in the 8 villages covered by the 
Bonconto health post. Study participants were randomly selected from the list of children 
who participated to the survey in December, using a random number generator from Excel 
TM
 
software. Children aged from 1 to 10 years with haemoglobin level below 11 g/dl were 
considered as anaemic and represented the cases while control participants were eligible if of 
same age group (1 to 10 years) and their haemoglobin level was at least 11 g/dl. 
Sample size calculation 
Among the investigated factors, malaria is known to be a common risk factor associated to 
anaemia; thus, malaria prevalence was used as the main outcome for sample size estimation. 
Based on 80% power, 5% significance level, assuming an overall carriage of malaria 
parasitaemia among non anaemic children in the study area at 22% (Senegal Malaria 
indicator survey 2009), a minimum odds ratio of 2 and a ratio case/control =1, a number of 
354 participants (177 cases and 177 controls) was required in this study. 
Data collection 
Clinical assessment 
Each child was examined by a physician prior to a biological assessment which included 
blood, stool and urine samples. The mother was interviewed directly to determine socio-
demographic characteristics as well as the child history of fever, using a standard 
questionnaire. Symptoms presented by each child at the day of survey as well as data 
obtained from physical examination and the parent interview were assigned in a case report 
form (CRF). 
Anthropometric measurements 
Children’s weight and height were measured by a trained field worker. Weightforage Zscore 
was used to denote underweight while height-for-age Z-score was used as an indicator of 
stunting. The Zscores were calculated based on the median values of the National Centre for 
Health Statistics (NCHS) reference population, United States. 
Laboratory methods 
Parasites detection 
Blood samples were collected using finger prick blood. The first drop was used for thick and 
thin smear tests for the diagnosis of malaria. Thick and thin smear tests were stained with 
Giemsa. Parasite density was determined by counting the number of asexual parasites per 200 
white blood cells, and calculated per μl using the following formula: numbered parasites x 
8000 / 200, assuming a white blood cell count of 8,000 cells per μl. Absence of malaria 
parasites in 200 high power ocular fields of the thick film was considered as negative. 
Fresh stools samples were collected into clean containers. Faecal samples were examined for 
the detection of intestinal parasites using Ritchie technique. Intestinal parasites were recorded 
positive by the presence of helminths and/or protozoans in the faeces. 
Urine samples were collected into clean containers between 10 to 14 h. To determine the 
presence of Schistosoma haematobium eggs in urine, a filtration method using polycarbamate 
nucleopore filters was used. One aliquot of 10 ml of urine sample was filtered and placed on 
a slide and examined using light microscopy 
Haemoglobin concentration determination 
A drop of finger prick blood was drawn into a microcuvette for Hb determination (g/dl) using 
a HemoCue machine (HemoCue Hb 201®). Anaemia was defined as Hb concentration below 
11 g/dl. 
Due to some logistical constraints, samples for haemoglobin concentration, malaria parasite 
investigation and haemoglobin genetic disorders investigation, were collected in December 
2010, while stool and urine samples were collected later in January two weeks after the first 
samples drawn. 
Identification of human genetic polymorphisms in study participants 
Samples and DNA extraction 
Blood samples were collected on filter paper from 352 children who participated in the 
survey in December 2010. DNA was extracted from segments of bloodspots on filter paper in 
96 well plate formats by chelex-100 methods as described elsewhere [26]. Haemoglobin A, S, 
C and the G6PD B, A and A-, were determined using PCR followed by a sequence-specific 
oligonucleotide probe enzyme-linked immunosorbent assay (SSOP-ELISA) while alpha-
thalassemia was detected by PCR alone [20-27]. 
Polymerase chain reaction (PCR) conditions 
Primers were used to amplify a 352 base-pair (bp) fragment of the G6PD gene covering the 
mutation site at codon 68 [27]. The haemoglobin gene was amplified by primers described by 
Modiano et al. [9] to produce a 358 bp fragment covering the mutation sites at codon 6 and 
26. Primers were biotinylated at the 5′end by the supplier (MWG Biotech, Ebersberg, 
Germany) [20]. For alpha thalassemia, primers were used to produce bands of 2200 + 1900 
bp representing the African α-globin variants [28]. 
The PCR conditions for both the G6PD and HbB gene were similar to the conditions 
described in [20]. The reactions were performed in 96 well PCR plates on a DNA thermal 
cycler. Alpha thalassemia PCR products were visualized by electrophoresis on a 0.75% 
agarose gel. 
SSOP-ELISA 
The procedures have been described in [20], in brief; oligonucleotide probes of 18 bases 
covering the SNP of interest were used where the 3′ end was conjugated with digoxigenin. 
Amplified PCR products were diluted 1:2 in dH2O, denatured at 95°C for 5 minutes. Two μl 
of the PCR products were added to streptavidin coated (1μl/ml PBS) ELISA plates containing 
washing buffer (PBS with 0.05% Tween 20) and incubated for one hour at room temperature. 
The bound PCR products were incubated with 8 nM of probe in tetra-methyl ammonium 
chloride (TMAC) solution at 53°C with shaking for an hour. TMAC washing temperatures 
were set to 62°C for haemoglobin probes and 65°C for the G6PD probes. The plates were 
incubated with peroxidase conjugated antidigoxigenin antibodies (Roche Diagnostics) 1:1000 
in washing buffer at room temperature for one hour, thereafter visualized by o-phenylene-
diamine (OPD). The reaction was stopped with H2SO4 before measuring the optical density at 
492 nm. Between each step, the ELISA plates were washed three times in washing buffer. 
Data management and data analysis 
Data were entered in Excel 
TM
 software and analysed using STATA 11
TM
 software. To assess 
the nutritional status, data were transferred into Epi Info. The Zscores for weightforage 
(underweight) and heightforage (stunting) were derived using Epinut Anthropometry (Epi 
Info sowfware). Children who had z scores below −2 standard deviations (SD) of the NCHS 
median reference population were considered to be malnourished. G6PD deficiency (G6PD 
A-) was defined as hemizygotes males and/or homozygote females. Sickle cell disease was 
represented by the homozygote state for haemoglobin S (HBSS) while the heterozygote state 
(HBAS, HBAC), represented sickle cell trait. Alpha-thalassemic children were represented 
by hetero and homozygote children. For categorical data, percentage was used to assess the 
frequency of each outcome. For continuous data, mean and standard deviation were used to 
describe normally distributed variables, median and range for other data. Characteristics of all 
children included in the study were tabulated by study group. Proportions were compared 
using chi square test or Fisher exact test where appropriated (univariate analysis); 
significance level of the different tests was set on 0.05, two sided. A stepwise logistic 
regression was done for the determination of risk factors possibly associated with anaemia. 
Ethical considerations 
This study was approved by the Senegalese National Ethical Committee (Conseil National de 
Recherche en Santé). Informed consent was obtained from parents or children guardian at the 
time of survey. 
Results 
Study participants characteristics 
A total number of 352 children less than 10 years of age were enrolled in the study (176 cases 
and 176 controls). Children less than 5 years represented 69% in the anaemic group and 26% 
in the non-anaemic group (p=0.001). The proportion of boys was 60% in the anaemic group 
and 53% in the non-anaemic group (p=0.13). A proportion of 50% in both groups had access 
to seasonal intermittent preventive treatment with SP-AQ. Bed-net ownership in the anaemic 
group represented 100%, while that for the non-anaemic group represented 98%. (p=0.08) 
(Table 1) 
Table 1 Socio demographic characteristics of study participants 
                          Anaemic group (176)                                    Non anaemic group (n=176) 
Characteristics Number (%) 95%CI  Number (%) 95%CI p value 
Age group      
Under 5 121 (68.75) [57.04-82.14] 46 (26.14) [19.13-34.86] 0.001 
[5 - 10 years] 54(30.68) [23.05-40.03] 130 (73.86) [61.71-87.70] 0.001 
Female   69 (39.20)        [30.50-49.61]    83 (47.16)        [37.56-58.46] 0.13 
Male 106 (60.27) [49.31-72.84] 93 (52.84)    [42.65-64.73] 0.16 
Children within 
household 
     
[1 – 3] 85 (48.29) [38.58-59.72] 58 (32.95) [25.02-42.60] 0.003 
[4 -5] 52 (29.54) [22.06-38.74] 68 (38.64) [30.00-48.98] 0.07 
>5 38 (21.59) [15.28-21.63] 50 (28.41) [21.08-37.45] 0.13 
Birth order      
[1 -3] 106 (60.22) [49.31-72.84] 109 (61.93) [50.85-74.71] 0.74 
[4 – 5] 42 (23.86) [17.19-32.25] 40 (22.73) [16.23-30.95] 0.80 
>5  27 (15.34) [10.11-22.32] 27 (15.34) [10.11-22.32] 1 
Access to IPTc with 
SP-AQ 
88 (50) 
  
[40.10-61.60] 88 (50) [41.10-61.60] 1 
Bed-net ownership 176 (100) [85.7-116] 173 (98.30) [84.19-114] 0.08 
Among the 176 children in the anaemic group, 122 (69.3%) were less than five years old 
while the remaining proportion (30.6%) had an age ranged from 5 to 10 years. Overall, mild 
anaemia was predominant in children above the age of 5 years (63%). Moderate anaemia 
represented a proportion of 48.4% in children less than 5 years and 33.3% in children with an 
age from 5 to 10 years (p=0.06). Few children were found with severe anaemia: 6.5% among 
under 5 years and 3.7% in children above 5 years (p=0.68) (Table 2). 
Table 2 Frequency and severity of anaemia among cases stratified by age group 
 
Under 5years  
(N=122) 
[5 - 10years] 
 (N=54) 
 
 
n (%) 95%CI n (%) 95%CI p value 
Mild anaemia (Hb<11g/dl) 55 (45.1) [34.0-58.7] 34 (63.0) [43.6-87.9] 0.03 
Moderate anaemia (Hb <9g/dl) 59 (48.4) [36.8-62.4] 18 (33.3) [19.7-52.7] 0.06 
Severe anaemia (Hb<7g/dl) 08 (6.5) [2.8-12.9] 02 (3.7) [0.4-13.4] 0.68 
Parasitic infections among study participants 
Plasmodium falciparum parasites were identified in 11 children (3.12%). Prevalence of P. 
falciparum was evaluated at 5.11% and 2.14%, respectively in anaemic children and non-
anaemic children (p=0.03). 
A total number of 97 children (27%) were found with at least one intestinal parasite. The 
identified intestinal parasites were represented by: Giardia intestinalis (12%), Entameaba 
coli (17%), Strongyloides stercoralis (0.6%). Hookworms, Schistosoma haematobium and 
Schistosoma mansoni were not found. (Table 3) 
Table 3 Overall prevalence of parasitic infections, erythrocytes polymorphisms and 
malnutrition among study participants 
Outcome No / Total No (%) 95%CI 
Malaria parasitaemia 11/352 (3.12) [1.56-5.59] 
Intestinal parasite carriage 97/352 (27.56) [22.35-33.62] 
Isolated intestinal parasites 
  Giardia intestinalis 43/352 (12.22) [8.84-16.45] 
Entameaba coli 61/352 (17.33) [13.25-22.26] 
Strongyloides stercoralis 02/352 (0.57) [0.06-2.05] 
Genetic disorders 
  G6PD A 07/352 (1.99) [0.79-4.09] 
G6PD A- 03/352 (0.85) [0.17-2.49] 
Alpha-thalassemia 
(Hetero+Homozygote) 78/352 (22.16) [17.51-27.65] 
Heterozygote (αα/-α) 62/352 (17.61) [13.50-22.58] 
Homozygote (-α/-α) 16/352 (4.55) [2.60-7.38] 
Sickle cells disorders (HBSS + HBAS 
+HbAC) 45 (12.78) [9.32-17.10] 
Sickle cell disease (HBSS) 10/352 (2.84) [1.36-5.22] 
Sickle cell trait (HBAS, C) 33/352 (9.38) [6.45-13.17] 
Malnutrition 
  Stunting 136/352 (38.64) [32.42-45.70] 
Underweight 91/352 (25.85) [20.81-31.74] 
Wasting 33/352 (9.38) [6.45-13.17] 
A total number of 42 children (24%) in the anaemic group were found with at least one 
intestinal parasite compared to 55 children (31%) in the non-anaemic group (p=0.12). The 
prevalence of isolated intestinal parasites was similar between the two study groups. (Table 
4). 
Table 4 Prevalence of parasitic infections, erythrocytes polymorphisms and 
malnutrition in each study arm 
                          Anaemic group (n=176)                          Non anaemic group (n=176) 
Characteristics Number (%) 95%CI Number  95%CI p value 
   (%)   
Malaria parasitaemia 9 (5.11) [2.34-9.70] 2 (1.14) [0.13-4.10] 0.03 
Intestinal parasite 
carriage 
42 (23.86) [17.19-32.26] 55 (31.25) [23.54-40.67] 0.12 
Parasite species      
Giardia intestinalis 21 (11.93) [7.39-18.23] 22 (12.50) [7.83-19.92] 0.87 
Entameaba  coli 26 (14.77) [9.65-21.64] 35 (18.89) [13.81-27,65] 0.20 
Strongyloides 
stercoralis 
00 -- 02 (1.14)  [0.13-4.11] 0.15 
Sickle cells      
AS patients 22 (12.57) [7.83-19.92] 11 (6.25) [3.11-11.18] 0.04 
SS patients 07 (3.97)    [1.59-8.19] 03 (1.70)  [0.35-4.98] 0.19 
AC patients 01 (0.57)    [0.01-3.16] 01 (0.57)   [0.01-3.16]    1 
Alpha thalassaemia 
(Hetero and 
homozygotes) 
48 (27.27)   [20.11-36.16] 30 (17.05) [11.50-24.33] 0.02 
Heterozygotes Alpha 
thalassemia 
37 (21.02)  [14.80-28.97] 25 (14.20) [9.19-20.97] 0.09 
Homozygotes Alpha 
thalassemia 
11 (6.25)   [3.11-11.18] 05 (2.84) [0.92-6.23] 0.12 
G6PD (B) 148 (84.09) [71.08-98.78] 134(76.14) [63.79-90.17] 0.06 
G6PD (A) 3 (1.70)   [0.35-4.98] 4 (2.27) [0.61-5.81] 0.70 
G6PD (A-) 3 (1.70)   [0.35-4.98] 00 -- 0.08 
Stunting 91 (51.70) [41.62-63.48] 45 (25.57) [18.64-34.21] 0.001 
Underweight 61 (34.66)  [26.51-44.52] 30 (17.05) [11.50-24.33]   0.001 
Wasting 15 (8.52)   [4.77-14.06] 18 (10.23) [6.06-16.16]  0.58 
Erythrocytes polymorphism among study participants 
The overall prevalence of sickle cell trait (HbAS and HbAC) was evaluated at 9.94% (35 
children) where the majority (33 children) were HbAS while two children were found with 
HbAC. Children with sickle disease (HbSS) represented 2.8% (10 children).-). Sickle cell 
disease (HbSS) represented 3.9% (7 children) in the anaemic group and 1.7% (3 children) in 
the non-anaemic group (p=0.19). A total number of 23 anaemic (13%) and 12 non-anaemic 
children (6.8%) were found with sickle cell trait (HbAS or HBAC), respectively (p=0.04). 
Heterozygote alpha-thalassemia (αα/-α) was found in 62 children (17.6%) and homozygote 
alpha-thalassemia was detected in 16 children (4.5%). Thus, in total the prevalence of alpha-
thalassemia (hetero and homozygote) was 22.1% (78 children). Alpha-thalassemia (Hetero 
and homozygotes) was detected in 48 anaemic children (27.2%) and in 30 non-anaemic 
children (17%) (p=0.02). Heterozygote alpha-thalassemia was prevalent in 21% of anaemic 
children and 14% of non-anaemic children (p=0.09). Homozygote alpha-thalassemia 
represented 6.2% in the anaemic group (11 children) and 2.8% (5 children) in the non-
anaemic group (p=0.12). (Table 4) 
The G6PD A was detected in 7 children (2%) while 3 children (0.8%) were caring the G6PD 
A-. Comparison between the two study groups showed a prevalence of G6PD (A) at 1.7% (3 
children) in the anaemic group and 2.2% (4 children) in the non-anaemic group (p=0.70). The 
G6PD (A-) was detected in 3 anaemic children (1.7%) while no child in the non-anaemic 
group was found with G6PD (A). 
Nutritional status 
The overall prevalence of stunting among study participants was evaluated at 38.64% (136 
children) while underweight and wasting represented 25.85% and 9.38%, respectively (Table 
3). Among anaemic children, stunting represented 52% (91 children), whereas only half, 26% 
(45 children) in the non-anaemic group (p=0.001). Prevalence of underweight was 34% (61 
children) in the anaemic group versus 17% (30 children) in the non-anaemic group (p=0.001). 
Wasting was found in a proportion of 8% and 10% respectively in anaemic and non-anaemic 
children (p=0.58) (Table 4). 
Factors associated with anaemia among study participants 
In a logistic regression analysis, anaemia was in overall significantly associated with malaria 
parasitaemia (aOR=5.2, 95%CI [1.1-28.4]), Sickle cell disorders (aOR=2.8, 95%CI [1.3-
6.3]), Alpha-thalassemia (aOR=1.8, 95%CI [1.2-3.3]), and stunting (aOR=3.4, 95%CI [1.9-
5.9]. Age group was also significantly associated with anaemia, adjusted OR at 0.1 for 
children aged from 2 to 4 years and 0.03 for children above 5 years of age. (Table 5) 
Stratified by age group, anaemia was significantly associated with stunting in children less 
than 5 years (aOR=3.1 95%CI [1.4 – 6.8]). In children aged from 5 to 10 years, the risk 
factors significantly associated with anaemia were represented by: stunting (aOR=3.6 95%CI 
[1.6 – 8.2]), sickle cell disorders (aOR=3.5 95%CI [1.4 – 9.0]), alpha-thallasemia (aOR=2.4 
95%CI [1.1 – 5.3]) (Table 6). The study did not find any statistically significant association 
between intestinal parasites and anaemia, nor between anaemia and co-infection with more 
than one intestinal parasite. 
Table 5 Distribution of factors associated with anaemia among study participants 
                                                         Frequency                                         Multivariate analysis 
 Anaemic 
group (n=176) 
Non anaemic 
group (n=176) 
aOR (95%CI) p value 
Variables     
Gender     
Female 69 (39.43%) 83 (47.16%) Reference  
Male 106 (60.57) 93 (52.84%) 1.37 [0.82-2.31] 0.22 
Age group     
1year 57 (32.76%) 8 (4.55%) Reference  
[2- 4 years] 89 (51.15%) 73 (45.48%) 0.13 [0.05-0.31] 0.001 
[5 – 10 years] 28 (16.09%) 95 (53.98) 0.03 [0.01-0.08] 0.001 
Access to IPTc drug 
(SP-AQ) 
    
No 87 (49.71%) 88 (50%) Reference  
Yes 88 (50.29%) 88 (50%) 0.78 [0.45-1.33]  
Stunting     
No 84 (48%) 131 (74%) Reference  
Yes 91 (52%) 45 (25.57%) 3.37 [1.93-5.88] 0.001 
Malaria 
Parasitaemia 
    
No 166 (94.86%) 174 (98.86%) Reference  
Yes 9 (5.14%) 2 (1.14%) 5.23 [1.1-28.48] 0.04 
Sickle cell disorders     
No 145 (82.86%) 161 (91.48%) Reference  
Yes 30 (17.14%) 15 (8.52%) 2.89 [1.32-6.34] 0.008 
Alpha Thalassemia     
No 128 (73.14%9 146 (82.95%) Reference  
Yes 47 (28.86%) 30 (17.05%) 1.82 [1.2-3.35] 0.04 
aOR: adjusted odds ratio. IPTc: Intermittent Preventive Treatment in children. SP-AQ: 
Sulfadoxine-Pyrimethamine. Goodness-of-fit-test: Hosmer-Lemeshow, Chi2 (8df)=5.07, 
p=0.75 
Table 6 Risk factors significantly associated with anaemia in children less than 5 years 
and children aged from 5 to 10 years at the Bonconto health post, Senegal 
Risk Factors aOR 95%CI p value 
Children under 5 years (n=122)* 
   Stunting 3.1 [1.4 - 6.8] 0.004 
Children aged 5 to 10 years (n=54)  
   Stunting 3.6 [1.6 - 8.2] 0.002 
Sickle cell disorders 3.5 [1.4 - 9.0] 0.009 
Alpha-thalassemia 2.4 [1.1 - 5.3] 0.026 
*Analysis of risk factors associated to anaemia among children under 5 years was adjusted on 
the following variables: P. falciparum infection, G6PD deficiency, Sickle cell disorders, 
Alpha-thallassemia, Access to IPTc drug (SP-AQ), gender. The number of anaemic children 
in this age group was = 122. Goodness of fit test: Hosmer-Lemeshow, chi(8df)=0.99, p=0.99. 
† Analysis of risk factors associated to anaemia among children aged from 5 to 10 years was 
adjusted on the following variables: P. falciparum infection, G6PD deficiency, Access to 
IPTc drug (SP-AQ), gender. The number of anaemic children was= 54. Goodness of fit test: 
Hosmer-Lemeshow, chi(6df)=4.22, p=0.64 
Discussion 
Although anaemia aetiologies are often multi-factorial, most studies have been confined to 
the anaemia associated with malaria or other individual factors [22-25]. This study 
investigated several factors potentially associated to anaemia among children less than 10 
years living in rural area in Senegal. In this area, recently, a randomized trial prior to the 
present case control study was conducted to assess the impact on malaria of combining home 
based management and intermittent preventive treatment [14]. Thus, children involved in the 
case control study, had access to several antimalarial interventions and furthermore, the area 
has a high coverage of impregnated bed nets. 
The high coverage of antimalarial interventions in the study area, and the fact that the study 
was conducted at the end of the malaria transmission season, could explain the low 
prevalence of malaria parasitaemia among the study participants (3.1%). Still, malaria 
prevalence was higher in anaemic children compared to non anaemic children and was 
closely associated to anaemia. Thus, scaling up antimalarial interventions at community level 
such as early case detection and treatment, intermittent preventive treatment as well as long 
lasting insecticide treated nets, may be a step towards malaria elimination, but will as well 
reduce the burden of anaemia. However, other aetiologies need to be considered for an 
effective and integrated control of anaemia. 
Intestinal protozoan infections (Giardia intestinalis, Entameaba coli) were the predominant 
parasites isolated from stool samples among the study participants. No significant association 
between these parasites and anaemia was observed. Despite that, G. intestinalis may induce 
diarrhoea and mal-absorption syndrome, which can lead to vitamin B12 deficiency as well as 
iron deficient anaemia [29]. The low prevalence of intestinal helminthic infections could be 
explained as a result of regular mass deworming administration program in the study area. 
Indeed, two mass de-worming campaigns using mebendazole (June and December every 
year) were undertaken in the study period as part of a national policy aiming at improving 
child survival. As Giardia is still prevalent in the area of Bonconto and it has the potential to 
induce diarrhoea and mal-absorption syndrome, this parasite could be targeted by public 
health programs. Thus, shifting from mebendazole to albendazole, which may be used against 
giardiasis, could contribute to further reduce it in children. 
Sickle cell disorders (HbAS, HbAC and HbSS) among study participants were frequent with 
an overall prevalence at 12.8% which are consistent with other findings; Mbodj et al. in 2003, 
reported a prevalence of HbAS and HbSS in the general population in Senegal at 11.1% [30], 
in line with Diop et al. findings in 2005, of 10% [31]. Alpha-talassaemia (hetero and 
homozygote) was more prevalent among study participants (22%). In 2006, Nabias et al. 
reported a similar prevalence of alpha-thalassemia (24%) in a cohort of children aged from 2 
to 10 years living in a rural area of Senegal [32]. Sickle cell disorders and alpha-thalassemia 
were strongly associated with anaemia in this study and thus may play a major role in the 
global burden of anaemia in developing countries [2]. Indeed, as child survival improves, and 
malaria is decreasing in many African countries, [13] inherited haemoglobin disorders could 
become an increasingly important disease burden and cause of anaemia in the future [33] i.e. 
beneficial balanced polymorphisms may become unbalanced. However, lack of adequate 
diagnostic tools in poor African settings can in this context, impact negatively on the 
investigation of anaemia related to genetic haemoglobin disorders. Therefore, there is a need 
to strengthen health systems diagnostic capacities in African settings, in order to optimize the 
investigation of genetic haemoglobin disorders and their consequences such as anaemia. 
In this study, a low prevalence of G6PD deficiency was found: G6PD (A-) patients 
represented a proportion of 0.85%. This is much less than the 12.3% reported in another 
study from Senegal [31]. G6PD deficiency is usually asymptomatic but can lead to 
haemolytic anaemia under oxidative stress [19]. Although no significant association was 
found between the prevalence of G6PD deficiency and anaemia in this study, this genetic 
disorder was more prevalent in anaemic children. 
Malnutrition was frequent in this study with an overall prevalence of 38% for stunting, 25% 
for underweight and 9% for wasting. Stunting was closely associated to anaemia. 
Malnutrition is known to be a leading factor to anaemia [34]. An inadequate intake of macro 
and micronutrients, or intestinal mal-absorption induced or increased by intestinal parasites 
infections, can play through iron and folate deficiency, a well-documented role in chronic 
anaemia pathophysiology [5]. 
Overall, malaria parasitaemia, stunting and some human genetic disorders represented the 
major causes of anaemia among study participants. Malaria and stunting can be controlled 
individually or together by developing integrated interventions targeting malaria and 
malnutrition. A study conducted at the Bonconto health post showed that home based 
management of malaria can be combined with intermittent preventive treatment, both 
delivered by community health workers with a significant impact on malaria and anaemia 
[14]. In addition micronutrient supplementation could be combined to home based 
management of malaria and IPTc in order to further reduce malnutrition and anaemia 
prevalence in children less than 10 years. However, studies are needed in such area in order 
to document the feasibility as well as the impact of such strategies on child survival. Some 
studies have shown that vitamin A and iron supplementation (alone), may actually negatively 
impact child survival and malaria outcome [35,36]. The potential benefit of iron 
supplementation coupled with effective malaria controls for children living in malaria-
endemic regions, need to be investigated. 
Study limitations 
This study has provided useful data for anaemia prevention and control. The study was 
designed as a case control study. Although selection of controls was restricted to children 
aged from 1 to 10 years, children less than 5 years were predominant in the anaemic group. 
To control for confounding induced by age group, multivariate analysis was done with 
adjustment by age group among other factors. 
Iron deficiency has been shown to be an important factor in the pathophysiology of anaemia. 
Details on iron deficiency and other micronutrients deficiencies (which have not have not 
been evaluated in this study), would add to revealing anaemia aetiologies in this part of 
Senegal. The role of iron deficiency in anaemia occurrence varies according to age groups. 
Indeed, a study conducted recently in Ivory Coast, found a high prevalence of iron deficiency 
in infants, without however any significant association with anaemia among infants [37]. 
Among preschool children, living in areas with high prevalence of soil transmitted helminthic 
infection (STH) such as hookworm, iron deficiency can play a major role in anaemia 
occurrence [37]. In this study, no child was found with hookworm infection, neither 
Schistosoma which could contribute to iron deficiency anaemia. 
Conclusion 
Malaria parasitaemia, stunting and haemoglobin genetic disorders represented the major 
causes of anaemia among children between 1 and 10 years participating in this study. 
Anaemia control in this area could be achieved by developing integrated interventions, 
targeting both malaria and malnutrition. 
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